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Background: Transient elastography (TE) offers a noninvasive correlate with the degree of hepatic fibrosis using the liver’s viscoelastic properties. 
Factors other than fibrosis affect liver stiffness. We sought to determine whether hepatic congestion related to hemodynamics influences liver 
stiffness measurements (LSM) assessed by TE.
methods: This was a prospective cohort study of subjects with Fontan circulation undergoing cardiac catheterization with or without liver biopsy. 
Subjects underwent TE within 5 days before the procedure. Clinical history, hemodynamic and biopsy data, and hepatic biomarkers were collected. 
Five subjects who previously underwent liver biopsy and TE were also included.
results: Data were collected on 50 subjects: 45 with hemodynamics, 10 with biopsy. Median age was 13.1y (range 2.4-57.8), and median 
time since Fontan was 9.9y (range 0.1-32.5). No subject had known hepatitis C. Mean LSM for the entire cohort was 21.4 ± 10.8 kPa. Univariate 
regression analysis using LSM as a continuous outcome variable is presented in Table 1. LSM is associated with more severe centrilobular fibrosis (p 
= 0.05). On multiple regression analysis, Fontan pressure (β = 0.901, p = 0.03) and cardiac index (β = -2.703, p = 0.02) were significant predictors 
of LSM with overall model R2 = 0.206.
conclusions: Higher LSM is associated with unfavorable Fontan hemodynamics and advanced centrilobular hepatic fibrosis. TE may be a useful 
screening tool for identifying patients who warrant invasive testing. 
Table 1. Univariate linear regression analysis using LSM as outcome variable.
n Regression coefficient P value Pearson correlation
Gender (Female) 50 0.751 0.81 -
Ventricular morphology (Left) 50 3.396 0.27 -
Patent fenestration 50 -5.964 0.07 -
Age at Fontan (y) 50 0.241 0.28 0.16
Age at LSM (y) 50 0.275 0.01 0.35
Time from Fontan to LSM (y) 50 0.481 0.003 0.41
RA/Fontan pressure (mmHg) 45 0.901 0.04 0.31
PAWP (mmHg) 45 0.527 0.24 0.18
MAP (mmHg) 45 -0.046 0.74 -0.05
CI (L/min/m2) 45 -2.704 0.03 -0.33
PVR (Wood units, indexed) 40 3.409 0.03 0.34
Systemic arterial O2 saturation (%) 45 0.513 0.04 0.31
Systemic venous O2 saturation (%) 45 0.026 0.89 0.02
Platelets (k cell/µL) 49 -0.038 0.05 -0.29
AST (U/L) 28 -0.202 0.27 -0.22
ALT (U/L) 28 -0.028 0.90 -0.03
GGT (U/L) 21 0.092 0.06 0.42
Albumin (g/dL) 29 5.179 0.17 0.26
Total protein (g/dL) 28 4.263 0.07 0.35
Total bilirubin (mg/dL) 27 1.933 0.57 0.12
